Making A.I.’s vile claims and made-up facts even worse is the fact that these chatbots are designed to be liked. They flatter ...

Artificial intelligence is now designing custom proteins in seconds—a process that once took years—paving the way for cures to diseases like cancer and antibiotic-resistant infections. Australian ...

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

Zipline drones help to deliver blood supplies to hospitals across rural western Rwanda, helping to cut waiting times from ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of ...

Secretary Kennedy’s latest maneuver seeks to expand vaccine injury lawsuits, echoing a precarious time in US history when ...

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

In the last year, there has been a surge in proteins developed by AI that will eventually be used in the treatment of ...

Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed ...

Merck & Co., Inc. (NYSE:MRK) is one of the 10 best defensive stocks to buy in a volatile market. On July 2, UBS reiterated a ...

In April of that year, patients started appearing at hospitals in the industrial city of Sverdlovsk, now known as ...

Added funding, biosecurity measures and a vaccine rollout may be playing a major role in limiting disasters caused by ...